Regain your health

Treatment of Chagas disease

Tractament de la malaltia de Chagas a Vall d'Hebron

Currently, there are two medications that are used to treat Chagas disease:  benznidazole and nifurtimox. 

Hospital o serveis complementaris relacionats

General Hospital

Where to find it

Description

In the event of a cardiac and/or digestive disease, specific treatment is required.

 
Related professionals
Sra. Carmen
Ferrer Barbera
Nursing Supervisor
Infectious Diseases
Vall d'Hebron University Hospital
More information
Location >
Dr. Israel
Molina Romero
Doctor
Infectious Diseases
Vall d'Hebron University Hospital
Lead Researcher
Vall d'Hebron Research Institute
More information
Location >
Dr. Adrián
Sánchez Montalvá
Doctor
Infectious Diseases
Vall d'Hebron University Hospital
Researcher
Vall d'Hebron Research Institute
More information
Location >
Dr. Pau
Bosch Nicolau
Doctor
Infectious Diseases
Vall d'Hebron University Hospital
Doctor
Vall d'Hebron Research Institute
More information
Location >
Dr. Adrià
Curran Fàbregas
Doctor
Infectious Diseases
Vall d'Hebron University Hospital
Researcher
Vall d'Hebron Research Institute
More information
Location >
Dr. Fernando
Salvador Vélez
Doctor
Infectious Diseases
Vall d'Hebron University Hospital
Researcher
Vall d'Hebron Research Institute
More information
Location >
Dr. Vicenç
Falcó Ferrer
Doctor
Infectious Diseases
Vall d'Hebron University Hospital
More information
Location >
Sra. Desideria
Martinez Rascon
Nurse
Infectious Diseases
Vall d'Hebron University Hospital
More information
Location >
 
Educació sanitària relacionades
Meningitis a Vall d'Hebron
Health tips for patients with meningitis
3295
Malaltia de Chagas a Vall d'Hebron
Health tips for people with chronic phase of Chagas disease
3277
 
News and events
Vall d'Hebron performs the first pancreatic tail resection with the Da Vinci robot 14/11/2018
Entrega Ajuts Recerca La Marató 2017
Five research projects on infectious diseases receive funds from La Marató de TV3 31/10/2018
Vall d'Hebron es convertirà en la seu d’ICORD, organització referent mundial en malalties minoritàries
As of 2019, Vall d'Hebron will become the headquarters of ICORD, a worldwide reference organization in rare diseases 18/10/2018
Vall d’Hebron and Daniel Bravo Foundation open the new Cystic Fibrosis Unit, a European pioneer 04/07/2018
Juvenile ALS is a very singular and rare type of Amyotrophic Lateral Sclerosis 21/06/2018
recerca, nanomedicina, vhir
A new European project awarded to the CIBBIM-Nanomedicine of the VHIR converts the Vall d'Hebron Campus into the health institution with the most active research projects in Nanomedicine of Europe 26/04/2018
April, Fabry disease awareness month 25/04/2018
recerca, assaigs clinics, vhio, vhir, conveni
Campus Vall d'Hebron signs a Prime Site Agreement with IQVIA, the world's largest clinical trial management company 24/04/2018
Study questions the concept that high fat meals induce satisfaction and digestive well-being 19/04/2018
VIH, VHIR
Study invalidates molecule that identified cells latently infected with HIV 18/04/2018